Cáceres-Nazario, Beatriz https://orcid.org/0009-0007-0607-0316
Rivenbark, Joshua https://orcid.org/0000-0002-7120-6677
Saha, Manish K.
Mathews, Stephanie
Rubinstein, Samuel M. https://orcid.org/0000-0002-5568-4441
Article History
Received: 21 August 2024
Accepted: 4 October 2024
First Online: 17 October 2024
Declarations
:
: The Office of Human Research Ethics at the University of North Carolina Chapel Hill has issued a determination that the research presented here does not constitute human subjects research as defined under federal regulations and does not require institutional review board (IRB) approval.
: The participant has consented to the submission of the case report to the journal.
: Joshua Rivenbark: Research support from Agios; Manish K. Saha: Honoraria from Calliditas, Travere, ChemoCentryx, and Elsevier; Samuel M. Rubinstein: Ad-hoc consulting with EUSA pharma, Janssen, BMS, Sanofi, Lava Therapeutics; Beatriz Cáceres-Nazario and Stephanie Mathews have no competing interests.